Last week, friends of the Paula Takacs Foundation for Sarcoma Research gathered virtually to present a check for $225,000 to Levine Cancer Institute. The celebration was led by executive director Susan Udelson and included messages of thanks from sarcoma patients and physicians at Levine Cancer Institute. With this gift, Atrium Health will continue to invest in critical sarcoma research to improve the lives of adults and children treated for sarcomas at Atrium Health Levine Cancer Institute and Levine Children’s Hospital.
Since 2013, the Paula Takacs Foundation has raised over $1.3 million for groundbreaking research at Atrium Health. Most recently, funding has supported an ongoing, homegrown clinical trial designed to improve treatments and outcomes for patients with sarcomas. The trial, which has shown promising results, was selected for a prestigious poster discussion at ASCO’s (American Society of Clinical Oncology) annual meeting in May 2020 – the world’s largest oncology meeting which was held virtually due to COVID-19.
Jeffrey S. Kneisl, MD; Joshua C. Patt, MD, MPH, FAOA; Michael B. Livingston, MD; Colin J. Anderson, MD; and Megan H. Jagosky, MD work closely with the Paula Takacs Foundation to advance sarcoma research at Levine Cancer Institute.
“The Paula Takacs Foundation believes in expanding hope globally for sarcoma cures by investing in local sarcoma research for all types of pediatric and adult sarcomas,” shared Susan Udelson, Executive Director of the Paula Takacs Foundation for Sarcoma Research. Since Levine Cancer Institute’s establishment in 2012, fundraising efforts have exclusively benefited Levine Cancer Institute and Levine Children’s Hospital, ensuring patients have access to cutting-edge treatment closer to home. Levine Cancer Institute is proud to be at the forefront of groundbreaking research for rare cancers. With support from the Paula Takacs Foundation, Atrium Health will continue to propel itself closer to developing a cure for the devastating disease.